CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-06-29, per its 10-Q filed 2013-07-31.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax · last filed 2013-07-31
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2013-06-29 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2013-03-30 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $712.00K.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) 6 month |
|---|---|---|
| 2013-06-29 | $0.00 10-Q · filed 2013-07-31 | $0.00 10-Q · filed 2013-07-31 |
| 2013-03-30 | $0.00 10-Q · filed 2013-05-08 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-07-31 | $712.00K 10-Q · filed 2013-07-31 |
| 2012-03-31 | $712.00K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |